Company
United StatesPublic company, NASDAQ: ANIPANI Pharmaceuticals, Inc (NASDAQ: ANIP), East Windsor, NJ – FDA Inspections
Inspection records and compliance data for ANI Pharmaceuticals, Inc in East Windsor, NJ. 1 FDA inspection on record, 1 Form 483, last inspected August 27, 2026. Publicly traded as NASDAQ: ANIP.
Company Profile
This profile covers ANI Pharmaceuticals, Inc based in East Windsor, NJ, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected August 27, 2026.
Most cited issue areas
- Failure to investigate serious, unexpected events1 inspection
- Failure to maintain records1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 27, 2026 | Not classified | Human Drugs · Postmarket Surv. and Epidemiology | 1288062 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
ANI Pharmaceuticals, Inc
Stock ticker
ANIP
Exchange
NASDAQ
Share price
$71.06
Market cap
$1.6B
Price as of
November 13, 2026
FEI Number
3021337460
Address
70 Lake Dr, East Windsor, NJ 08520-5321, United States
Country
United States
ID: 620b0adb-0720-47fc-89ee-61de63f05c57